• Fate Therapeutics - Guiding Cells to New Health
  • Home
  • Careers
Print
  • ABOUT FATE
  • SCIENCE & TECHNOLOGY
  • LEADERSHIP
  • NEWS & EVENTS
    • Press Releases & News
    • Event Calendar
    • For Media
    • Stay Informed
  • STEM CELLS 101
  • CONTACT US

Press Releases & News

  • 2010
  • 2009
  • 2008
  • 2007

Press Releases

  • 2010-06-28
  • Fate Therapeutics Receives Red Herring’s North America 100 Award for Advancing Stem Cell Technology and New Medicines
  • 2010-05-11
  • Fate Therapeutics Expands Scientific Advisory Board to Advance iPSC Technology and Stem Cell Modulator Pipeline
  • 2010-05-10
  • Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
  • 2010-04-08
  • Fate Therapeutics Expands Stem Cell Modulator Pipeline with Acquisition of Verio Therapeutics
  • 2010-02-26
  • Fate Therapeutics Named One of the 50 Most Innovative Companies in the World By MIT's Technology Review
  • 2010-02-04
  • Fate Therapeutics Receives Allowance of First U.S. Patent for Induced Pluripotent Stem Cell Technology

In the News

  • 2010-06-20
  • The San Diego Union-Tribune: New Kids on the Block
  • 2010-04-08
  • Xconomy: Fate Therapeutics Expands its Stem Cell Empire Into Canada
  • 2010-02-23
  • Technology Review: Technology Review's 50 Most Innovative Companies
  • 2010-02-05
  • Bloomberg/BusinessWeek: Fate Therapeutics, MIT Scientist Get Stem Cell Patent
  • 2010-02-05
  • San Diego Daily Transcript: Fate Therapeutics Receives Patent Allowance

Please see disclaimer on third party links.

  • Privacy Policy
  • © 2010 Fate Therapeutics